Small molecules dominate FDA drug approvals this month
This August saw nine new green lights from the FDA, all small molecules, which makes up a third of the approvals this year.
List view / Grid view
This August saw nine new green lights from the FDA, all small molecules, which makes up a third of the approvals this year.
According to a recent article, drug companies are developing longer-acting, injectable HIV treatments.